Citation only
via Europe PMC
Obesity pharmacotherapies and cognition.
Börchers S, Mazzini G, Zetterberg H, Clemmensen C.
Science (New York, N.Y.) · 2026
Abstract
Pharmacotherapies for obesity and type 2 diabetes are increasingly being evaluated for their effects on cognition and brain health. Evidence from preclinical models, observational cohorts, and clinical trials has intensified interest, but findings remain mixed. A central challenge is to determine whether potential cognitive effects arise from direct actions on neural circuits, indirect consequences of improved cardiometabolic health, or both. This Review examines the evidence across cardiometabolic disease, aging, and Alzheimer's disease, focusing on glucagon-like peptide-1 (GLP-1)-based therapies and combination approaches that engage glucose-dependent insulinotropic polypeptide, glucagon, and amylin pathways. We assess how receptor pharmacology, brain exposure, metabolic context, and disease stage shape cognitive outcomes and discuss how mechanistic clarity could guide therapies aimed at preserving or improving cognition.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1126/science.aek9987
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
S, B., G, M., H, Z., & C., C. (2026). Obesity pharmacotherapies and cognition. <em>Science (New York, N.Y.)</em>. https://doi.org/10.1126/science.aek9987
Vancouver
S B, G M, H Z, C. C. Obesity pharmacotherapies and cognition. Science (New York, N.Y.). 2026. doi:10.1126/science.aek9987.
BibTeX
@article{brchers2026Obesit,
title = {Obesity pharmacotherapies and cognition.},
author = {Börchers S and Mazzini G and Zetterberg H and Clemmensen C.},
journal = {Science (New York, N.Y.)},
year = {2026},
doi = {10.1126/science.aek9987},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preprints.org 2021
Preprint · CC-BY
The Effects of Intermittent Fasting on Brain and Cognitive Function
National Institute on Aging (NIA) 2010
Open access · US-GOV
A Pilot Study of Exendin-4 in Alzheimer s Disease
Nutrients 2021
Open access · CC-BY
The Effects of Intermittent Fasting on Brain and Cognitive Function
Neurobiology of Aging 2017
Preprint · OA
Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease
International Journal For Multidisciplinary Research 2026
Open access · CC-BY
Intermittent Fasting and Cognitive Performance in Adults: A Narrative Review
Oxidative Medicine and Cellular Longevity 2012
Open access · CC-BY